# Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets

> **NCT07112235** · — · RECRUITING · sponsor: **Imperial College London** · enrollment: 50 (estimated)

## Conditions studied

- COPD (Chronic Obstructive Pulmonary Disease)
- Rhinovirus Infection
- Exacerbation of COPD

## Interventions

- **BIOLOGICAL:** Rhinovirus-A16

## Key facts

- **NCT ID:** NCT07112235
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-08
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07112235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07112235, "Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07112235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*